Potential therapeutic and pharmacological strategies for SARS-CoV2

BACKGROUND: At the end of 2019, the new Coronavirus disease 2019 (COVID-19) strain causing severe acute respiratory syndrome swept the world. From November 2019 till February 2021, this virus infected nearly 104 million, with more than two million deaths and about 25 million active cases. This has p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Pharm Investig
Asıl Yazarlar: Ghareeb, Doaa A., Saleh, Samar R., Nofal, Mohammed S., Kaddah, Mohamed M. Y., Hassan, Salma. F., Seif, Inas K., El-Zahaby, Sally A., Khedr, Shaimaa M., Kenawy, Marwa Y., Masoud, Aliaa A., Soudi, Salma A., Sobhy, Ahmed A., Sery, Jaillan G., El-Wahab, Miral G. Abd, Elmoneam, Alshimaa A. Abd, Al-mahallawi, Abdulaziz Mohsen, El-Demellawy, Maha A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Singapore 2021
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933375/
https://ncbi.nlm.nih.gov/pubmed/33688448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40005-021-00520-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller